跳到正文
MarketHOT
English
摘要
SEC · EDGAR 财务披露·· 11 天前精选AI 评分21

Cardinal Health 提交 8-K,披露截至 9 月 30 日季度业绩公告及 webcast 安排

CARDINAL HEALTH INC (0000721371) (Filer)

AI 导读

Cardinal Health 于 11 月 5 日提交 Form 8-K,称已发布截至 9 月 30 日季度业绩公告,公告作为 Exhibit 99.1 附件提交。公司安排在美国东部时间 11 月 5 日上午 8:30 举行 webcast,讨论季度业绩及截至 2027 年 6 月 30 日财年的展望;演示文稿和音频回放将在投资者页面提供。

正文

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2026

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

Ohio1-1137331-0958666
(State or other
jurisdiction of incorporation)

(Commission

File Number)

(IRS Employer
Identification No.)

7000 Cardinal Place, Dublin, Ohio 43017

(614) 757-5000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p


Item 2.02: Results of Operations and Financial Condition

On November 5, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September 30, 2026. A copy of the news release is included as Exhibit 99.1 to this report.

Item 7.01: Regulation FD Disclosure

During a webcast scheduled to be held at 8:30 a.m. Eastern time on November 5, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September 30, 2026 and outlook for the fiscal year ending June 30, 2027. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.

Item 9.01: Financial Statements and Exhibits

(d) Exhibits

Exhibit
Number
Exhibit Description
99.1

News release issued by the Company on November5, 2026 announcing first-quarter results.

2


Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cardinal Health, Inc.
(Registrant)
Date:November 5, 2026By:/s/ AARON E. ALT
Aaron E. Alt
Chief Financial Officer

3

来源:SEC EDGAR · 本站存档